CLINICAL CHARACTERISTICS OF RECURRENT UPPER GASTROINTESTINAL BLEEDING DUE TO PEPTIC ULCERS AFTER ENDOSCOPIC HEMOSTASIS
Main Article Content
Abstract
Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is a common medical and surgical emergency, in which rebleeding after initial endoscopic hemostasis is a serious complication affecting patient prognosis. This study was conducted at the Emergency and Intensive Care Department, Hanoi Medical University Hospital, to describe the clinical, paraclinical characteristics and endoscopic findings in patients with rebleeding during the period from January 2022 to April 2025. A total of 337 patients aged ≥ 16 years with UGIB caused by peptic ulcers and treated with endoscopic hemostasis were included; among them, 26 cases (7.7%) experienced rebleeding, predominantly male (73.1%), with a mean age of 60 years. The most common ulcer site was the anterior duodenal bulb (73.1%), and the average length of hospital stay was 20.4 ± 18.8 days. Forrest classification, ulcer location, and volume of transfused blood were not independent predictors of rebleeding or clinical outcomes. Additionally, early rebleeding (≤ 72 hours) showed no statistically significant association with treatment outcomes.
Article Details
Keywords
Gastrointestinal bleeding, gastric and duodenal ulcers, recurrent bleeding
References
2. Long ĐV. Xuất huyết tiêu hóa do loét dạ dày tá tràng. In: Bệnh học nội khoa. Nhà xuất bản Y học; 2016:38-45.
3. Điệp PTH, Phương BK, Ly HTT. Kết quả kẹp clip cầm máu trong xuất huyết tiêu hóa do loét dạ dày tá tràng. Tạp Chí Khoa Học Tiêu Hóa Việt Nam. Published online 2018:3112-3118.
4. Tâm HH. Hiệu quả của tiêm HSE hoặc kẹp cầm máu qua nội soi phối hợp với thuốc ức chế bơm proton liều cao tĩnh mạch ở bệnh nhân xuất huyết tiêu hóa do loét dạ dày tá tràng. Tạp Chí Dược Học Cần Thơ. Published online 2019:22-25.
5. Świdnicka-Siergiejko A, Rosołowski M, Wróblewski E, Baniukiewicz A, Dąbrowski A. Comparison of the efficacy of two combined therapies for peptic ulcer bleeding: adrenaline injection plus haemoclipping versus adrenaline injection followed by bipolar electrocoagulation. Gastroenterol Rev. 2014;6:354-360. doi:10.5114/ pg.2014.47898
6. Sehested TSG, Carlson N, Hansen PW, et al. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction. Eur Heart J. 2019; 40(24): 1963-1970. doi:10.1093/eurheartj/ ehz104
7. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. The Lancet. 2002;359(9300):14-22. doi:10.1016/s0140-6736(02)07273-2
8. Messer Julio, Reitman Dinah, Sacks Henry S., Smith Harry, Chalmers Thomas C. Association of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease. N Engl J Med. 1983;309(1): 21-24. doi:10.1056/ NEJM198307073090105
9. Hearnshaw SA, Logan RFA, Lowe D, Travis SPL, Murphy MF, Palmer KR. Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut. 2010;59(8):1022-1029. doi:10.1136/gut.2008.174599
10. Laine L, Jensen DM. Management of Patients With Ulcer Bleeding. Am J Gastroenterol. 2012;107(3):345-360. doi:10.1038/ajg.2011.480